Eye Diseases

237 trials 74 recruiting

Filter these 237 trials by phase, country and sponsor.

Open in Search →

A study of efgartigimod PH20 SC given by prefilled syringe in adults with thyroid eye disease Ended

2023-509198-22-00 Thyroid Eye Disease (TED) 5 2024-10-21
A study of efgartigimod PH20 SC given by prefilled syringe in adults with thyroid eye disease Ended

2023-509197-35-00 Thyroid Eye Disease (TED) 5 2024-10-17
A study to learn about the blood levels of aflibercept when high-dose aflibercept is injected in both eyes of participants with diabetic mac… Ended

2024-511665-11-00 Neovascular age-related macular degeneration (nAMD) 6 2024-08-29
A Study for Comparing a Generic Combination of Brinzolamide and Timolol Eye Drops versus Azarga® Eye Drops in the Treatment of Patients with… Ended

2023-506494-35-00 Ocular Hypertension 5 2024-07-15
An open-label study for participants who are non-responders at the end of treatment assessment on the VRDN-001-101 and VRDN-001-301 pivotal … Ended

2023-507350-33-00 Thyroid eye disease 5 2024-06-25
Non-inferiority study between two formulations Brimonidine 0.2%/Timolol 0.5% eye drops solution Ended

2023-507285-24-00 Open angle glaucoma is characterized by increased intra 5 2024-05-31
Comparison of efficacy and safety of BP05 product and product of Lucentis in patients with Wet Age related Macular Degeneration Ended

2023-507459-31-03 wet macula degeneration 5 2024-05-22
A study to evaluate safety and efficacy of two different concentrations of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF… Ended

2023-507561-26-00 Dry Eye 4 2024-05-17
A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybu… Ended

2023-504477-21-01 male/female outpatients, aged 0-17 years scheduled to u 5 2024-05-14
A study to evaluate safety and efficacy of two different doses of Isocyclosporin A eye drop solution in patients with Atopic Keratoconjuncti… Ended

2023-508907-19-00 Atopic keratoconjunctivitis (AKC) 4 2024-05-10
Bioequivalence study on aqueous humour concentrations of active ingredients after topical application of LEVIOSA® versus F2904. Randomized,… Ended

2023-503722-39-00 Cataract 2 2024-04-22
A Safety, Tolerability and Efficacy Study of VRDN-001 in Persons with Chronic Thyroid Eye Disease (TED) Ended

2023-507217-10-00 Thyroid eye disease 5 2024-04-12
A Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia Ended

2023-506707-25-00 Choroidal neovascularization secondary to pathologic my 5 2024-04-09
RANDOMIZED, OPEN LABEL, PARALLEL-GROUP, TWO-ARM, MULTICENTER STUDY WITH CLINICAL ENDPOINT COMPARING PRESERVATIVE FREE BIMATOPROST OPHTHALMIC… Ended

2023-504759-28-00 Ocular Hypertension 5 2024-04-05
A Study to Evaluate the Efficacy and Safety of LASN01 in Patients with Thyroid Eye Disease Ended

2023-508161-32-00 Thyroid Eye Disease 4 2024-03-28
The GOBLET trial: A clinical trial on GOblet cell density after Benzalkonium chloride and preservative-free Latanoprost Eye drop Treatment Ended

2024-512275-12-00 Ocular hypertension 6 2024-03-19
Clinical study to evaluate the handling and safety of AVT06 PFS in subjects with chorioretinal vascular disease (ALVOEYE-D). Ended

2023-505225-13-00 chorioretinal vascular disease (neovascular age-related 5 2024-03-11
Treating discharge and discomfort of eye prosthesis: a comparison between vitamin A ointment, anti-inflammatory eye drops and standard eye d… Ended

2023-504451-27-01 Chronic mucopurulent discharge and/or discomfort of the 6 2024-02-29
Extension Study to Assess Batoclimab in Participants with TED. Ended

2024-512650-21-00 Thyroid Eye Disease (TED) 5 2023-12-13
Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease. Ended

2024-512648-45-00 Thyroid Eye Disease (TED) 5 2023-11-30
A Study to Evaluate Linsitinib in Subjects with Active, Moderate to Severe Thyroid Eye Disease (TED) Ended

2022-502812-35-00 Thyroid Eye Disease 4 2023-10-26
A study to investigate the safety, tolerability, pharmacokinetics, and early signs of biological activity of danegaptide following oral admi… Ended

2023-503683-16-00 Diabetic macular edema 3 2023-10-16
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 Macular edema secondary to retinal vein occlusion 5 2023-09-13
Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis (JAKUVEITE) Ended

2024-513802-77-00 Active non-anterior non-infectious uveitis 5 2023-08-30